Distraction Osteogenesis Devices Market to Surpass US$ 348.2 Million by 2027- CMI

Global Distraction Osteogenesis Devices Market, by Device Type (Mandibular Distraction Devices, Palatal Distraction Devices, Alveolar Distraction Devices, Cranial Distraction Devices, LeFort Distractor Devices, Small Bone Distractor Devices, and Others), by Placement (Internal Distractors and External Distractors), by End User (Hospitals, Orthopedic Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at US$ 228.3 million in 2018 and is expected to exhibit a CAGR of 4.9% over the forecast period (2019-2027), as highlighted in a new report published by Coherent Market Insights.

The rising development and launch of technologies by key players, which would help surgeons to make critical preoperative decisions and allow efficient execution of the procedures, for achieving desirable patient outcomes are expected to propel the market growth over the forecast period. For instance, in March 2019, Stryker Corporation introduced the new 1688 visualization platform designed to enhance orthopedic surgical efficiency and patient experience.

The rising prevalence of cleft palate among children is expected to augment the market growth over the forecast period. For instance, in 2016, according to reports published in the Brazilian Journal of Oral Sciences, prevalence of nonsyndromic cleft lip with or without cleft palate is estimated to be 0.36 to 1.54 per 1,000 live births in Brazil.

Also, initiatives by several organizations for providing surgical care for facial deformities is a major factor propelling the market growth. For instance, the World Craniofacial Foundation links families in great need with medical professionals in every continent to ensure that the children with facial deformities receive high surgical and medical care. The foundation has transformed the lives of children with international expertise and medical resources.

Browse 35 Market Data Tables and 17 Figures spread through 169 Pages and in-depth TOC on ‘Distraction Osteogenesis Devices Market, by Device Type (Mandibular Distraction Devices, Palatal Distraction Devices, Alveolar Distraction Devices, Cranial Distraction Devices, LeFort Distractor Devices, Small Bone Distractor Devices, and Others), by Placement (Internal Distractors and External Distractors), by End User (Hospitals, Orthopedic Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2027”

To know the latest trends and insights prevalent in the distraction osteogenesis devices market, click the link below:

https://www.coherentmarketinsights.com/market-insight/distraction-osteogenesis-devices-market-1172

North America is expected to hold dominant position in the distraction osteogenesis devices market over the forecast period, owing to rising number of cleft palate and other bone defects in the region. According to the Centers for Disease Control and Prevention, 2019, around 1 in every 1,600 babies are born with cleft lip with cleft palate each year in the U.S.

Asia Pacific is expected to witness significant growth in the distraction osteogenesis devices market over the forecast period, owing to rising expansion and investment by the market players, to expand their customer base and geographical presence in the region. For instance, in 2016, KLS Martin Group opened its Indian subsidiary, KLS Martin India Private Limited in Chennai, with the aim of expanding its presence in Asia Pacific. Also, organizations such as Inga Health Foundation India run three centers to treat skull and facial deformities in children across the country, which is expected to help in reducing the prevalence of craniofacial deformities. According to a survey by INGA Health Foundation in 2016, craniofacial abnormalities occur in one out of every 2,000 newborns. Around 15,000 infants with craniofacial deformities are born every year, whereas cleft palate affects one in every 600 births in India.

Key Takeaways of the Distraction Osteogenesis Devices Market:

The global distraction osteogenesis devices market is expected to exhibit a CAGR of 4.9% over the forecast period, owing to increasing number of bone defects and rising adoption of collaboration and acquisition strategies by the market players. For instance, in 2017, Titamed collaborated with Royal Belgium Society of Stomatology and Maxillofacial Surgery and MKA Wassland, and conducted an event at the European Association for Cranio Maxillo- Facial Surgery Congress in April 2018, to promote and showcase its range of products to maxillofacial surgeons, thus enhancing sales of its products in the market.
Among placement, the external distractors segment held a dominant position in the distraction osteogenesis devices market in 2018. This is owing to increasing research and development activities for the development of external distractors. For instance, according to the research conducted by Department of Cleft Lip and Palate, Plastic Surgery Hospital and Chinese Academy of Medical Sciences in association with Department of Stomatology of Beijing Children’s Hospital, China published a study in Nature Research Journal in January 2019, on the use of Trans-sutural distraction osteogenesis (TSDO), an external distractor, for treating cleft lip and palate (CLP) in patients with midfacial hypoplasia.
Among end user, hospitals segment held a dominant position in the distraction osteogenesis devices market in 2018, owing to rising number of tailored pediatric treatments offered by hospitals. For instance, in May 2017, surgeons and surgical orthodontists at the Seattle Children’s Hospital used 3-D Imaging and advanced software to build precise maps of the face and skull, and also developed a process to shorten the distractor time.
Key players operating in the global distraction osteogenesis devices market include Johnson & Johnson, Zimmer Biomet Holdings, Inc., Stryker Corporation, KLS Martin Group, Acumed LLC, OsteoMed, and Titamed